Lee Ainslie Corcept Therapeutics Inc Transaction History

Maverick Capital LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$19.2 - $24.47 $358,214 - $456,536	18,657 New	18,657 $404,000
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $826,347 - $1.34 Million	-49,246 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$12.46 - $19.98 $70,000 - $112,247	-5,618 Reduced 10.24%	49,246 $857,000
Q2 2020 Aug 14, 2020	BUY	$11.0 - $18.26 $603,504 - $1 Million	54,864 New	54,864 $923,000

355

86.2M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.17B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.